Global Oral Antidiabetic Drugs Market Growth, Share, Size, Trends and Forecast (2020 - 2026)

Segmented by Drug Class Analysis;

Sulfonylureas - Glimepiride, Gliclazide, Glyburide and Others, Meglitinides - Repaglinide and Nateglinide, Biguanides - Metformin and Others, Alpha-glucosidase inhibitors - Acarbose, Voglibose and Others.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2016 - 2026).
Report ID: Rn804412413 Published Date: November, 2020 Updated Date: February, 2021
Download Free Sample Now

Introduction

Global Oral Antidiabetic Drugs Market (USD Million), 2016 - 2026

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2016 - 2026
2016 107.1
2017 119.8
2018 123.7
2019 143.0
2020 160.8
2021 163.4
2022 168.7
2023 171.2
2024 200.3
2025 216.5
2026 230.2

In the year 2019, the Global Oral Antidiabetic Drugs Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2026, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drug Class Analysis
    2. Market Snapshot, By Region
    3. Market Opportunity Map
  4. Global Oral Antidiabetic Drugs Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Global Oral Anti-Diabetic Market Drivers: Impact Analysis
        2. Rising Prevalence Of Diabetes Mellitus
        3. Increase In Obesity
      2. Restraints
        1. Global Oral Anti-Diabetic Market Restraints: Impact Analysis
        2. High Cost of Drugs
      3. Opportunities
        1. Market Strength
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Oral Antidiabetic Drugs Market,By Drug Class Analysis, 2018 - 2028 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2020 and 2026 (%)
      3. Y-o-Y Growth Analysis, 2017 - 2026
      4. Segment Trends
        1. Sulfonylureas
          1. Introduction
          2. Market Share Analysis, 2020 and 2026 (%)
          3. Y-o-Y Growth Analysis, 2017 - 2026
          4. Segment Trends
            1. Glimepiride
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (USD Million)
            2. Gliclazide
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (USD Million)
            3. Glyburide
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (USD Million)
            4. Others
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (USD Million)
        2. Meglitinides
          1. Introduction
          2. Market Share Analysis, 2020 and 2026 (%)
          3. Y-o-Y Growth Analysis, 2017 - 2026
          4. Segment Trends
            1. Repaglinide
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (USD Million)
            2. Nateglinide
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (USD Million)
        3. Biguanides
          1. Introduction
          2. Market Share Analysis, 2020 and 2026 (%)
          3. Y-o-Y Growth Analysis, 2017 - 2026
          4. Segment Trends
            1. Metformin
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (USD Million)
            2. Others
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (USD Million)
        4. Alpha-glucosidase inhibitors
          1. Introduction
          2. Market Share Analysis, 2020 and 2026 (%)
          3. Y-o-Y Growth Analysis, 2017 - 2026
          4. Segment Trends
            1. Acarbose
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (USD Million)
            2. Voglibose
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (USD Million)
            3. Others
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (USD Million)
    2. Global Oral Antidiabetic Drugs Market, By Geography, 2018 - 2028 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2020 and 2026 (%)
      3. Y-o-Y Growth Analysis, 2017 - 2026
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
        4. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
        5. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2016 - 2026 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. Abbott Laboratories
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Biocon, Ltd
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Eli Lilly and Company
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. Sun Pharma Industries, Ltd
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Novo Nordisk A/S
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. Pfizer
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      7. Sanofi
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      8. Novartis
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

Research Methodology

As it might be evident by now, we named our company to represent our research methodology. We know what you are thinking by this point; of all the ways in which a company can be named, why to name it after research methodology?

The answer is straight and simple, it is the research methodology that separates Good Research from Great Research. Hence, we couldn’t find a better way to name our company.

Reanin Logo Image

As our name indicates, our research methodology involves 3 main steps:

  • Research – Involves market scoping followed by fixing of market taxonomy/segmentation and collection of both qualitative and quantitative data relevant to market segments.
  • Analysis – Involves analysis of the data collected in previous step to get an understanding of the market from different viewpoints.
  • Insights – Involves generating actionable insights using the market understanding that was developed in the previous step.

RESEARCH

STEP 1:
Market Scoping
  • In this step, we try to determine if there is a gap/potential for growth in the market that we are planning to study. This step is extemely important as it helps us to decide if, our insights can help the clients in filling a gap in the market or tap into the potential growth opportunities.
  • We proceed to next steps of research only if we find the gap/potential for growth in the market we are planning to study.

STEP 2:
Fixing Market Taxonomy
  • In this step, we study differnet ways in which the market can be segmented in order to facilitate the best possible analysis of the market followed by deriving actionable insights. By the end of this step, we segment the market in the best possible way.

STEP 3:

Data Collection MethodsApproaches/Sources
Primary Research
  • Paid primary calls
  • Cold Calling
  • Email Outreach
  • Surveys
  • In person interviews
Secondary Research
  • Databases
    • Paid
    • Free
  • Press Releases
  • Whitepapers
  • Company Websites
  • SEC Filings

Types of Data Collected

Qualitative Data

This involves collection of information regarding various factors that impact the market/market trends. The qualitative data inclues (but not lmited to):

  • Information on product/service launches
  • Information on product development breakthroughs (pipeline data collection).
  • Information on regulatory changes
  • Factors affecting price changes
  • Information on regional trends.
  • Information required to determne market drivers, restraints and opportuntinites.
  • Changes in Political, Economic, Social and Technological factors.
  • Information about business overview and strategy of key players in the market.
  • Information required for SWOT Analysis of companies.

Quantitative Data

This involves collection of data to determine market size, market share, company revenues etc. Some of the quantitative data includes (but not limited to):

  • Average Selling Price (ASP) of products.
  • Product Volume or the data that can help in determining product volume.
  • Company financials
  • Data required to determine company market share.

ANALYSIS

STEP 1:
Connecting the Dots/ Econometric Modelling/ Market Modelling/ Internal Analysis
In this step, we do the following
  • Data Consolidation.
  • Correlating between qulitative and quantitative data through econometric modelling.
  • Filling the gaps in data through market modeeling.
  • Indentifying data patterns and deriving market trends through internal analysis.

STEP 2:
Data Validation
  • In This step, we validate the collected data through triangulation of primary research data, secondary research data and the data derived through ReAnin Internal analysis.

STEP 3:
Market Forecasting
  • In this step, we preodct/forecast the future market size and market trends based on historical data patterns and market trends.
Research

Market Scoping

Fixing Market Taxonomy / Segmentation

Data Collection

Data Collection

Primary Research
Collection of Qualitative Data
Collection of Quantitative Data
Secondary Research
Collection of Qualitative Data
Collection of Quantitative Data
Analysis

Connectin the Dots/ Econometric Modeeling/ Market Modelling/ Internal

Data Validation

Market Forecasting

Insights
  • What's working and what's not
  • Strategies to improve revneues in near term.
  • Insights on possible product obsolescence in near term and long term.
  • Best go to market strategy for new companies / products.
  • Strategies / Actions for being future proof.
  • Investment Opportunities.
  • Exit Strategies (If applicable).

Why Buy This Report?

This report can help you in

  • Increasing your revenues by giving you access to information about key trends, innovative products and technologies, market segments and companies operating in this market.
  • Developing business strategies through better understanding of the trends shaping and driving this market.
  • Organizing your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
  • Tracking segment wise market size and share at Global, Regional and Country levels.
  • Improving your business strategy by giving you access to competitor information, analysis, and insights.
  • Identification of emerging players with potentially strong product portfolios and creating effective counter strategies to gain a competitive advantage.
  • Formulating market entry and market expansion strategies

The ReAnin Difference:

  • We are strong believers in client approach
  • We provide 100% free customization for all our deliverables
  • We provide free after sales analyst support for a period of 1 full year from the date of sale.
  • We know the difference between "Good Research" and "Great Research"
Download Free Sample Now

ReAnIn's Most Viewed Titles:

Healthcare Latest in Healthcare Organ Preservation Solutions
Global Organ Preservation Solutions Market Growth, Share, Size, Trends and Forecast (2020 - 2026)

In the year 2019, the Global Organ Preservation Solutions Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2026, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Orthodontics
Global Orthodontics Market Growth, Share, Size, Trends and Forecast (2020 - 2026)

In the year 2019, the Global Orthodontics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2026, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Biotechnology Oral Biologics
Global Oral Biologics Market Growth, Share, Size, Trends and Forecast (2020 - 2026)

In the year 2019, the Global Oral Biologics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2026, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Biotechnology Oral Proteins and Peptides
Global Oral Proteins and Peptides Market Growth, Share, Size, Trends and Forecast (2020 - 2026)

In the year 2019, the Global Oral Proteins and Peptides Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2026, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...